Show simple item record

Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?

dc.contributor.authorTurkoglu, S
dc.contributor.authorOkten, A
dc.contributor.authorPoturoglu, S
dc.contributor.authorBadur, S
dc.contributor.authorBesisik, F
dc.contributor.authorDanalioglu, A
dc.contributor.authorKAYMAKOĞLU, Sabahattin
dc.contributor.authorCakaloglu, Y
dc.contributor.authorDEMİR, Kadir
dc.contributor.authorAKYÜZ, Filiz
dc.contributor.authorAksoy, N
dc.date.accessioned2022-02-18T10:39:27Z
dc.date.available2022-02-18T10:39:27Z
dc.identifier.citationDanalioglu A., KAYMAKOĞLU S., Cakaloglu Y., DEMİR K., AKYÜZ F., Aksoy N., Poturoglu S., Turkoglu S., Badur S., Besisik F., et al., "Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?", Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 Mayıs 2003, cilt.124
dc.identifier.othervv_1032021
dc.identifier.otherav_affa1a4f-a534-4607-b850-a94ec7bbc5bd
dc.identifier.urihttp://hdl.handle.net/20.500.12627/179640
dc.identifier.urihttps://doi.org/10.1016/s0016-5085(03)83851-9
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectGastroenterology
dc.subjectHepatology
dc.subjectHealth Sciences
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleCombined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume124
dc.contributor.firstauthorID3372317


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record